Alexion Pharmaceuticals
+$3.05 (+1.70%) Today
$0.00 (0.00%) As of 11:21 PM UTC after-hours
Why Robinhood?
You can watch ALXN and buy or sell other stocks, options, and ETFs commission-free!
About ALXN
Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).
CEO
Marc Pierre Jean Dunoyer, MBA
Employees
—
Headquarters
Boston, Massachusetts
Founded
1992
ALXN Key Statistics
Market cap
40.34B
Price-Earnings ratio
59.70
Dividend yield
—
Average volume
14.86M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$187.45
52 Week low
$99.91
ALXN Earnings
$0.00
$1.17
$2.35
$3.52
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, Pre-Market